Order results by:
| Issue | Title | |
| Vol 11, No 2 (2019) | Possible timing for anticoagulation therapy initiation in ischemic stroke patients with atrial fibrillation: further analysis of the hemorrhagic transformation index | Abstract PDF (Eng) similar documents |
| M. N. Kalinin, D. R. Khasanova, M. M. Ibatullin | ||
| "... and 3 days after the onset of IS. There was a progressive NNT drop in patients with a HTI score of 0–1 ..." | ||
| Vol 6, No 3 (2014) | Myofascial pain: from Virchow's to our days | Abstract similar documents |
| I. V. Egorov | ||
| "... drugs and further to the increase of their doses because the treatment is ineffective. Modern-day ..." | ||
| Vol 5, No 3 (2013) | Analysis of factors influencing the early efficiency of systemic thrombolytic therapy for ischemic stroke | Abstract similar documents |
| Elena Vladimirovna Prazdnichkova, A M Alasheev, O A Shalagina, L I Volkova | ||
| "... . Improvement was observed in 66% of the patients on day 7. The mean NIHSS score on day 7 was 6.0 (range 4–12 ..." | ||
| Vol 7, No 3 (2015) | Efficiency of epilepsy treatment in the Moscow Region under the present-day conditions of drug provision | Abstract similar documents |
| Irina Gennadyevna Rudakova, Yu. A. Belova | ||
| Vol 14, No 3 (2022) | The efficacy of ipidacrine in patients with diabetic polyneuropathy | Abstract similar documents |
| P. R. Kamchatnov, E. R. Barantsevich, A. V. Chugunov, A. A. Kabanov, B. A. Abusueva | ||
| "... group, the total scores on the NSS scale decreased by 37% (p<0.05) by the 60th day of treatment ..." | ||
| Vol 16, No 2 (2024) | The use of thromboaspiration and combined treatment in patients with ischemic stroke in real-life clinical practice | Abstract similar documents |
| T. V. Volchenkova, S. V. Kotov, E. V. Isakova, M. V. Sutormin, E. V. Patrin, B. B. Gegenava, M. N. Martynovich, I. G. Rudakova, L. V. Smetana, V. A. Borisova, S. V. Belkina | ||
| "... Scale (NIHSS) scores at day 28, dynamics of NIHSS scores, Rankin scores at day 28, rates of hemorrhagic ..." | ||
| Vol 4, No 3 (2012) | Experience in correcting brain edema in cerebral infarction | Abstract similar documents |
| E V Eliseyev, T Yu Nedorostkova, Sofia Alekseyevna Rumyantseva, V V Afanasyev | ||
| "... of the disease. The baseline severity of neurological symptoms was 10.2±2.12 scores according to the National ..." | ||
| Vol 15, No 5 (2023) | Efficacy and safety of Vespireit® (buspirone) prolonged-release tablets (PR) 15 mg in the therapy of patients with functional dizziness: results of the double-blind, placebo-controlled, multicenter, randomized, phase 3 clinical trial | Abstract similar documents |
| M. V. Zamergrad, V. A. Parfenov, A. S. Agafina, N. V. Lyamina, M. M. Gavrik, L. R. Kuchumova, E. R. Barantsevich, V. S. Krasnov, A. A. Ivanova, A. L. Vladykin, K. А. Ishchenko | ||
| "... in total DHI for dizziness score at Visit 5 (day 28±1) compared with baseline (Visit 1, day 1). Secondary ..." | ||
| Vol 12, No 5 (2020) | Endovascular treatment results in patients with large cerebral artery occlusions in a metropolis. Moscow Stroke Registry data over 2019 | Abstract PDF (Eng) similar documents |
| D. V. Skrypnik, K. V. Anisimov, A. Yu. Botsina, T. V. Kiseleva, S. P. Grachev, N. A. Shamalov, E. Yu. Vasilyeva, A. V. Shpektor | ||
| "... functional recovery (MSR 0–2 scores) was observed in 213 (29.2%) patients. The 20-day mortality rate was 31 ..." | ||
| Vol 1, No 3-4 (2009) | TREATMENT FOR ACUTE NONSPECIFIC BACK PAIN IN OUTPATIENT PRACTICE | Abstract similar documents |
| O. N. Gerasimova, V. A. Parfenov | ||
| "... techniques. The patients took movalis in a dose of 15 mg/day orally or 15 mg/day intramuscularly for up to 5 ..." | ||
| Vol 13, No 2 (2021) | Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19) | Abstract similar documents |
| V. A. Kutashov | ||
| "... and 152 women) – were prescribed with actovegin 400 mg 3 times a day in addition to the baseline therapy ..." | ||
| Vol 11, No 3 (2019) | Treatment of patients with acute and subacute lumbodynia and lumbar ischialgia | Abstract similar documents |
| V. A. Parfenov, A. I. Isaikin, T. I. Kuzminova, O. A. Chernenko, O. V. Milovanova, A. V. Romanova, N. D. Samkhaeva, Yu. M. Shor | ||
| "... .5%), and piriformis syndrome and SIJ injury (2.5%). The duration of treatment averaged 11.0±2.4 days. By the end ..." | ||
| Vol 9, No 1 (2017) | The impact of sleep-disordered breathing on early functional recovery in ischemic stroke | Abstract similar documents |
| G. M. Lutokhin, L. A. Geraskina, A. V. Fonyakin, M. Yu. Maksimova | ||
| "... , cardiorespiratory monitoring was performed on 2–5 days after the onset of the disease. The total number of episodes ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... and regression of patient complaints were observed. After 45 days of therapy an increase in the mean MoCA score ..." | ||
| Vol 12, No 5 (2020) | The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study | Abstract PDF (Eng) similar documents |
| D. V. Ivashchenko, S. Z. Khoang, M. Kh. Tazagulova, B. V. Makhmudova, N. I. Buromskaya, P. V. Shimanov, R. V. Deitch, I. V. Dorina, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... CT+TT was associated with worse tolerance to pharmacotherapy on 14 day (the total score of the UKU ..." | ||
| Vol 5, No 2 (2013) | Neurasthenia: State-of-the-art and therapeutic approaches | Abstract similar documents |
| Leonid Semenovich Chutko, S Yu Surushkina, I S Nikishena, E A Yakovenko, T I Anisimova | ||
| "... as two administrations for 10 days (5 days at a 2-day interval). The results of therapy were assessed ..." | ||
| Vol 4, No 3 (2012) | Cognitive impairments in young people with opioid addiction and their correction | Abstract similar documents |
| Maria Lazarevna Chukhlovina | ||
| "... /day according to the degree of cognitive impairments for 3 months), there was a significant ..." | ||
| Vol 3, No 2 (2011) | Therapy of depression in patients with focal epilepsy: experience with citalopram use | Abstract similar documents |
| A. V. Lebedeva, E. G. Melikyan, A. B. Gekht | ||
| "... to the HADS: the mean scores for anxiety and depression were 13.38±2.15 and 11.19±3.28, respectively. After ..." | ||
| Vol 12, No 1 (2020) | The first experience with thrombolytic therapy for cerebral infarction in the Russian Federation after the use of idarucizumab | Abstract similar documents |
| E. V. Pudov, N. N. Sukhacheva, I. S. Petelina | ||
| "... fibrillation (AF) who took dabigatran 110 mg twice a day developed recurrent ischemic stroke (IS) that caused ..." | ||
| Vol 4, No 2 (2012) | Efficacy of paxil in the treatment of depressions in elderly males | Abstract similar documents |
| N A Tyuvina, S V Prokhorova, T N Maksimova | ||
| "... .3%)], and bipolar affective disorder [n = 9 (25.7%)] were examined. The efficacy of paxil 20—40 mg/day ..." | ||
| Vol 10, No 3 (2018) | Treatment of patients with acute and subacute dorsalgia | Abstract similar documents |
| O. N. Gerasimova, V. A. Parfenov, E. Yu. Kalimeeva | ||
| "... meloxicam 15 mg/day orally or intramuscularly or first 15 mg/day intramuscularly and then orally ..." | ||
| Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Surgical and medical treatments for discogenic low back radiculopathy | Abstract similar documents |
| M. A. Ivanova, V. A. Parfenov, A. O. Isaikin | ||
| "... 7–14 days and 0.84 vs 1.56 scores after 3 months; p < 0.05); however, this advantage did not persist ..." | ||
| Vol 12, No 1 (2020) | Comparative efficacy and tolerance of centrally acting muscle relaxants in elderly patients with nonspecific musculoskeletal pain | Abstract similar documents |
| R. V. Gorenkov, M. N. Dadasheva, I. A. Zolotovskaya, V. A. Kruglov | ||
| "... . At 15 days, treatment substantially reversed pain syndrome according to VAS scores in all the groups ..." | ||
| Vol 4, No 2 (2012) | The efficacy and tolerability of paroxetine (adepress), an antidepressant from a group of selective serotonin reuptake inhibitors, in psychoautonomic syndrome within anxiety-depressive disorders | Abstract similar documents |
| T G Voznesenskaya, N M Fokina | ||
| "... (paroxetine) was used in a dose of 10—20 mg/day for 8 weeks. Adverse reactions were observed in one-third ..." | ||
| Vol 10, No 3 (2018) | Effect of mexidol on the efficiency of intravenous thrombolytic therapy for ischemic stroke during the therapeutic window | Abstract similar documents |
| K. S. Knni, T. V. Dyomin, L. B. Adeeva | ||
| "... deficit, all the patients were divided into three subgroups: 1) mild IS (<8 NIHSS scores at admission); 2 ..." | ||
| Vol 5, No 3 (2013) | Diabetic peripheral neuropathy therapy-induced activation of humoral serotonin and endogenous neurotrophins | Abstract similar documents |
| Yuulia Vladimirovna Karakulova, N B Kaigorodova, E A Batueva | ||
| "... of 10.0 ml for 10 days. Prior to treatment, their pain intensity was 5.94±1.2 and 29.6±6.24 scores ..." | ||
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... tablet three times per day). Patients with CI (mean MoCA score ≤25 points; n=50) were prescribed ..." | ||
| Vol 17, No 3 (2025) | Predicting clinical outcomes in patients with ischemic stroke following successful thrombectomy: clinical, neuroradiological, and periprocedural predictors | Abstract similar documents |
| K. V. Anisimov, N. Kh. Gorst, A. B. Berdalin, A. V. Kostin, K. N. Zhuravlev, D. V. Skrypnik, N. A. Shamalov | ||
| "... disturbances (National Institutes of Health Stroke Scale, NIHSS score) on admission (OR 0.87; 95% CI 0.79–1 ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... coefficient R=-0.41) between the number of headache (HA) days per month and the MoCA score (p<0 ..." | ||
| Vol 4, No 1 (2012) | Experience in using sulpiride in non-psychotic endogenous depressive-hypochondriacal disorders | Abstract similar documents |
| Nina Arkadyevna Tyuvina, V. V. Balabanova, E M Goncharova | ||
| "... in an initial dose of50—100 mg/day; the dose was, if required, increased up to 400—600 mg/day. Results. After 2 ..." | ||
| Vol 15, No 1 (2023) | New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program | Abstract similar documents |
| E. Y. Solovieva, P. R. Kamchatnov, L. B. Novikova, O. A. Kicherova, N. M. Khasanova | ||
| "... (MoCA). An extension of the standard MoCA testing – MoCA-Memory Index Score (MoCA-MIS; Memory Index, MI ..." | ||
| Vol 13, No 5 (2021) | Insomnia in chronic non-specific low back pain | Abstract similar documents |
| I. A. Lamkova, V. A. Parfenov | ||
| "... was carried out three times (at the admission, after 7–10 and 80–90 days). Results and discussion. In both ..." | ||
| Vol 1, No 1 (2009) | ETORICOXIB: THERAPEUTIC POTENTIAL | Abstract similar documents |
| A. E. Karateev | ||
| "... to 120 mg/day), lower risk of gastrointestinal events, liver damage, and skin and respiratory reactions ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... . The starting dose of the drug was 2 mg/day in all the cases. Then it was increased once weekly until ..." | ||
| Vol 12, No 1 (2020) | Experience with vortioxetine in the treatment of post-stroke depression | Abstract similar documents |
| I. A. Strelnikova, A. A. Svetkina, Yu. D. Minina, O. V. Androfagina | ||
| "... ). Group 1 (a study group) included 30 patients who received vortioxetine 10 mg/day for 8 weeks; Group 2 ..." | ||
| Vol 10, No 3 (2018) | Conservative treatment for patients with discogenic lumbosacral radiculopathy: results of a prospective follow-up | Abstract similar documents |
| M. A. Ivanova, V. A. Parfenov, A. I. Isaikin | ||
| "... ) of Quality of Life (QoL) Questionnaire on admission to the clinic, at 7-14 days after treatment (pain ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... with vortioxetine at a dose of 15 or 20 mg/day for 8 months. The investigators used clinical and psychopathological ..." | ||
| Vol 3, No 3 (2011) | Cognitive functions in late periods after reconstructive operations on the carotid arteries | Abstract similar documents |
| T. P. Evdokimova, N. M. Lobova, L. A. Geraskina, P. A. Fedin, M. N. Guryev, Yu. V. Rodionova, S. I. Skrylev | ||
| "... ischemic changes in 27 (32%) patients on days 1-2. Results and discussion. As compared to the baseline ..." | ||
| Vol 6, No 2 (2014) | Experience with non-drug therapies (psychotherapy, phytotherapy, reflexotherapy) for neurasthenia | Abstract similar documents |
| S.A Bozhko, N.A. Tyuvina | ||
| "... inventory (MFI-20). Results. All the patients underwent a complete treatment cycle for 35 days. After ..." | ||
| Vol 12, No 4 (2020) | Experience with citicoline in patients with post-stroke cognitive impairment | Abstract similar documents |
| A. N. Bogolepova, S. G. Burd, A. V. Lebedeva, E. A. Kovalenko | ||
| "... (Ceresil® Canon) oral solution at a dose of 1000 mg/day for 3 months. Results and discussion. Citicoline ..." | ||
| Vol 8, No 2 (2016) | Effect of cerebrolysin on motor function restoration during medical rehabilitation | Abstract similar documents |
| M. A. Kustova, A. P. Tolmachev, N. A. Shamalov | ||
| "... efficiency criterion, the Action Research Arm Test (ARAT) scale, and total outcome 90 days after disease ..." | ||
| Vol 5, No 2 (2013) | Current possibilities of therapy for sleep disorders in Parkinson’s disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... to antiparkinsonian drugs, melatonin was given in a dose of 3 mg/day. The efficiency of the therapy was evaluated ..." | ||
| Vol 4, No 2 (2012) | Clinical experience with meloxicam (Movalis®) in nonspecific back pain and radiculopathy | Abstract similar documents |
| O N Gerasimova, V A Parfenov | ||
| "... of the treatment in patients with acute, subacute, or chronic pain was 12.1±5.2, 17.1±5.7, and 18.0±7.9 days ..." | ||
| Vol 15, No 4 (2023) | Experience with agomelatine therapy for non-psychotic depression with a single and recurrent course | Abstract similar documents |
| L. A. Ivanova, A. V. Kovaleva, N. O. Sitnikova | ||
| "... in scores on the HAMD-17 scale was noted in the remission group from the 7th day of agomelatine therapy (p<0 ..." | ||
| Vol 12, No 6 (2020) | The interaction of folate cycle enzyme genes and the risk of extrapyramidal side effects of antipsychotics | Abstract PDF (Eng) similar documents |
| T. V. Zhilyaeva, E. V. Akimova, A. S. Blagonravova, G. E. Mazo | ||
| "... Code F20). All the patients took antipsychotics for at least 7 hospital days were examined using real ..." | ||
| Vol 11, No 2 (2019) | Differentiated approach and indications for optimization of agomelatine therapy for endogenous depression | Abstract similar documents |
| L. I. Abramova, G. P. Panteleeva, I. Yu. Nikiforova, T. E. Novozhenova | ||
| "... over time on fixed days from a reduction in the mean total score (MTS) of the respective scales ..." | ||
| Vol 16, No 1 (2024) | Treatment of cognitive impairment in patients with cerebral infarction in the internal carotid arteries circulation system: results of a multicentre, randomized, double-blind, placebo-controlled clinical trial | Abstract similar documents |
| D. R. Khasanova, A. A. Yakupova, P. R. Kamchatnov, Zh. Yu. Chefranova, E. I. Bogdanov, P. I Pilipenko, N. M. Khasanova | ||
| "... into two groups: in the first group they received Prospecta for 90 days, in the second group placebo (PL ..." | ||
| Vol 17, No 1 (2025) | Contribution of genomic variation to the severity of multiple sclerosis | Abstract similar documents |
| O. G. Kulakova, N. A. Matveeva, I. S. Kiselev, A. N. Boyko, O. O. Favorova | ||
| "... of the disease. To describe the clinical course of MS, disease severity scores are used; they characterize ..." | ||
| Vol 12, No 2 (2020) | Myofascial pain syndrome in female patients with chronic nonspecific back pain: diagnosis and treatment | Abstract similar documents |
| D. O. Rozhkov, O. E. Zinovyeva, A. N. Barinov, I. M. Vikhlyantsev, G. Z. Mikhailova, N. V. Penkov, A. M. Nosovsky | ||
| "... .2 months; the mean pain intensity scores were 6.5±1.1 on a numerical rating scale). Six patients underwent ..." | ||
| Vol 6, No 1 (2014) | Apathy in Parkinson's disease patients | Abstract similar documents |
| M. R. Nodel | ||
| "... to the Hoehn and Yahr scale, 2.5) received pramipexole (1.5–3.0 mg/day) to correct motor disorders ..." | ||
| Vol 16, No 3 (2024) | Analyzing the predictors of relapse in drug-induced headache: a prospective clinical and psychological study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... of analgesic use per day (OR 15.8; 95% C113.1—23.4), degree of alexithymia (score on TAS-26 scale: OR 11.3; 95 ..." | ||
| Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
| A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
| "... short courses (up to 10 days per year) to achieve a long-term effect on the immune system. The dose ..." | ||
| Vol 1, No 1 (2009) | TENOTEN IN COMPLEX THERAPY FOR CEREBROVASCULAR INSUFFICIENCY IN ELDERLY PATIENTS | Abstract similar documents |
| L. D. Serova | ||
| "... of 20 patients. During 28 days, the study group patients received tenoten as a tablet thrice daily ..." | ||
| Vol 13, No 4 (2021) | IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy | Abstract similar documents |
| A. L. Kurenkov, L. M. Kuzenkova, V. V. Chernikov, B. I. Bursagova, A. A. Nezhelskaya, A. R. Artemenko | ||
| "... injections, which was demonstrated by a reduction in mean DIS score from 78.6±9.6 (min 62, max 95 points; 95 ..." | ||
| Vol 12, No 4 (2020) | The main clinical and diagnostic characteristics of patients with low back pain and sacroiliac joint diseases (results of the IOLANTA-II study) | Abstract similar documents |
| I. A. Zolotovskaya, I. L. Davydkin | ||
| "... involved three visits: V 1 (inclusion); V 2 (after 7 days), and V 3 (after 3 months); after the screening ..." | ||
| Vol 9, No 4 (2017) | Cognitive complaints and cognitive impairment in patients with chronic daily headache | Abstract PDF (Eng) similar documents |
| V. A. Golovacheva, V. A. Parfenov, A. A. Golovacheva | ||
| "... .9%) of patients with CHD complained of diminished memory; however, its mild disorders (25– 26 MCA scores) were ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Intellectual development of children born to mothers with epilepsy | Abstract similar documents |
| A. V. Yakunina, I. E. Poverennova, V. A. Kalinin, S. A. Ananyeva | ||
| "... the study group, the general, verbal and non-verbal intelligence quotient (IQ) scores were 126.6, 112 ..." | ||
| Vol 15, No 4 (2023) | Work factors affect work stress among lecturers: study in Indonesia | Abstract PDF (Eng) similar documents |
| D. F. Multamasatika, K. A. Akbar, R. I. Hartanti, K. Kallawicha | ||
| "... . The result showed that most participants had moderate stress (score: 59–92) and moderate workload (score: 50 ..." | ||
| Vol 17, No 3 (2025) | Autonomic cardiovascular dysregulation and other non-motor manifestations of Parkinson’s disease | Abstract similar documents |
| A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov | ||
| "... , the Spielberger State-Trait Anxiety Inventory, the Glasgow Dyspepsia Severity Score (GDSS), the Gastrointestinal ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... prescribed in two annual treatment cycles, each comprising 2 weeks with a treatment duration of 4—5 days ..." | ||
| Vol 9, No 4 (2017) | The course of cervical dystonia with head tremor during botulinum toxin type A treatment | Abstract similar documents |
| A. N. Korenko, A. A. Skoromets, A. A. Timofeeva, A. V. Tishkov | ||
| "... ; 41] to 30 [27; 33] scores by injection cycle 4 (p < 0.001) and to 26 [23; 27] scores by cycle 8 (p<0 ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... Expanded Disability Status Scale (EDSS) score was 4.0; the most severe course of the disease was observed ..." | ||
| Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
| D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
| "... -year risk of reaching 6.5 Expanded Disability Status Scale (EDSS) scores. Patients and methods ..." | ||
| Vol 12, No 2 (2020) | Efficacy of tolperisone versus meloxicam in the treatment of nonspecific acute neck pain | Abstract similar documents |
| K. V. Skorobogatykh, Yu. E. Azimova | ||
| "... for nonspecific acute neck pain with tolperisone 150 mg/day, followed by dose escalation up to 450 mg/day, versus ..." | ||
| Vol 9, No 3 (2017) | Capabilities of perfusion ASPECTS in predicting the efficiency of intravenous thrombolytic therapy | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, V. E. Drobakha, N. A. Kaileva, L. I. Syromyatnikova, Yu. A. Golosova, V. V. Shestakov | ||
| "... ), and mean transit time (MTT) in 10 brain regions in accordance with the Alberta Score Program Early CT Score ..." | ||
| Vol 13, No 5 (2021) | Alcohol-Induced Psychotic Disorder and Depressive Disorder: a Dual Diagnosis Case Series | Abstract PDF (Eng) similar documents |
| A. Elbelushi, Z. Muravec, H. Masood, B. Masood | ||
| "... Rating Scale (HDRS), Clinical Global Impression Severity score (CGI-S), Clinical Global Impression ..." | ||
| Vol 10, No 3 (2018) | Correlation of the aesthetic component of dental health and emotional state in patients with different anxiety levels | Abstract similar documents |
| O. I. Lobach, V. N. Nikolenko, E. K. Rustamova, N. V. Lapina, E. V. Kochurova, L. A. Skorikova, L. V. Gavrushova | ||
| "... materials made in Russian and foreign countries. Results. Before treatment, the state anxiety scores were 54 ..." | ||
| Vol 11, No 1 (2019) | Role of the intact hemisphere in determining the rehabilitation potential in the acute period of ischemic stroke: a diffusion and perfusion model | Abstract similar documents |
| N. A. Kaileva, A. A. Kulesh, N. Kh. Gorst, A. Yu. Bykova, V. E. Drobakha, K. V. Sobyanin, I. N. Shardakov, V. V. Shestakov | ||
| "... CBFV in 10 areas according to the Alberta stroke program early CT score (ASPECTS). Values for FA in 10 ..." | ||
| Vol 16, No 1 (2024) | A five-point scale for assessing the quality of life of patients with epilepsy | Abstract similar documents |
| P. N. Vlasov, V. A. Karlov, I. A. Zhidkova, A. O. Khabibova, A. M. Azhigova, V. A. Kharkovsky | ||
| "... school grading system, where 5 is an excellent grade, 4 is good etc. The resulting score serves ..." | ||
| Vol 16, No 4 (2024) | Validation of the Russian version of Swiss Narcolepsy Scale for narcolepsy type 1 screening | Abstract similar documents |
| A. O. Golovatyuk, A. S. Kuts, A. Yu. Melnikov, A. V. Zaharov, M. G. Poluektov, C. Bassetti | ||
| "... (ESS) questionnaires. Results. The mean score of the RU-SNS for patients with narcolepsy was – 33 ..." | ||
| 1 - 70 of 320 Items | 1 2 3 4 5 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
